YAP Promotes Malignant Progression of <i>Lkb1</i> -Deficient Lung Adenocarcinoma through Downstream Regulation of Survivin
Wenjing Zhang(Shanghai Institutes for Biological Sciences), Hongbin Ji(Westlake University), Zhongzhou Yang(Model Animal Research Center), Shun Yao(Chinese Academy of Sciences), Yijun Gao(Sun Yat-sen University), Fei Long(Second Military Medical University), Xinyuan Tong(Chinese Academy of Sciences), Lei Zhang(Shanghai Medical College of Fudan University), Fuming Li(Fudan University), Yan Ren(Shanghai Institutes for Biological Sciences), Xiangkun Han(Chinese Academy of Sciences), Heng‐Yu Fan(Zhejiang University)
Cited by 89
Related Papers
The impact of human EGFR kinase domain mutations on lung tumorigenesis and in vivo sensitivity to EGFR-targeted therapies
|Cancer Cell|2006|451
SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment
|Blood|2008|345
Stem Cell Factor SOX2 Confers Ferroptosis Resistance in Lung Cancer via Upregulation of SLC7A11
|Cancer Research|2021|280